ID21568A - Penggunaan baru untuk turunan 1,3-propanadiol - Google Patents

Penggunaan baru untuk turunan 1,3-propanadiol

Info

Publication number
ID21568A
ID21568A IDW990370A ID990370A ID21568A ID 21568 A ID21568 A ID 21568A ID W990370 A IDW990370 A ID W990370A ID 990370 A ID990370 A ID 990370A ID 21568 A ID21568 A ID 21568A
Authority
ID
Indonesia
Prior art keywords
propanadiol
new use
optionally substituted
chem
independently
Prior art date
Application number
IDW990370A
Other languages
English (en)
Inventor
Sylvain Cottens
Robert Paul Hof
Roland Wenger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID21568A publication Critical patent/ID21568A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Light Receiving Elements (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW990370A 1996-11-19 1997-11-17 Penggunaan baru untuk turunan 1,3-propanadiol ID21568A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9624038.7A GB9624038D0 (en) 1996-11-19 1996-11-19 Organic compounds

Publications (1)

Publication Number Publication Date
ID21568A true ID21568A (id) 1999-06-24

Family

ID=10803173

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990370A ID21568A (id) 1996-11-19 1997-11-17 Penggunaan baru untuk turunan 1,3-propanadiol

Country Status (24)

Country Link
US (3) US6274629B1 (id)
EP (2) EP0941082B1 (id)
JP (2) JP4004070B2 (id)
CN (2) CN1293876C (id)
AT (2) ATE275947T1 (id)
AU (1) AU728420B2 (id)
BR (1) BR9713105A (id)
CA (1) CA2270952C (id)
CZ (1) CZ174999A3 (id)
DE (2) DE69730727T2 (id)
DK (1) DK1312359T3 (id)
ES (2) ES2289041T3 (id)
GB (1) GB9624038D0 (id)
HU (1) HUP0000343A3 (id)
ID (1) ID21568A (id)
IL (1) IL129824A (id)
NO (1) NO992259L (id)
NZ (1) NZ335629A (id)
PL (1) PL190348B1 (id)
PT (2) PT1312359E (id)
RU (1) RU2217136C2 (id)
SI (1) SI1312359T1 (id)
SK (1) SK284806B6 (id)
WO (1) WO1998022100A2 (id)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1457478B1 (en) 1998-11-11 2017-07-19 Novartis AG Production of 2-amino-2-[2-(4-alkyl-phenyl)ethyl]propane-1,3-diols
WO2001043742A1 (en) * 1999-12-16 2001-06-21 Teva Pharmaceuticals Industries Ltd. Novel processes for making- and a new crystalline form of- leflunomide
EP1315735A4 (en) 2000-08-31 2005-04-06 Merck & Co Inc Phosphate derivatives as immunoregulatory compounds
BR0207434A (pt) * 2001-02-22 2004-07-06 Novartis Ag Uso de agentes de domiciliação acelerada de linfócitos para a fabricação de um medicamento para o tratamento de função retardada de enxertos
RU2290196C2 (ru) * 2001-04-20 2006-12-27 Дебиофарм С.А. Модифицированный циклоспорин, который можно использовать в качестве пролекарства, и его применение
RU2003136730A (ru) * 2001-06-08 2005-05-20 Новартис АГ (CH) Лечение или профилактика отторжения инсулин-продуцирующего клеточного трансплантата
GB0117921D0 (en) * 2001-07-23 2001-09-12 Novartis Ag Organic compounds
US7780993B2 (en) * 2001-09-07 2010-08-24 Yeda Research And Development Co. Ltd. Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
US20040136972A1 (en) * 2001-09-07 2004-07-15 Yeda Research And Development Co. Ltd. Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
GB0125443D0 (en) 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
AU2003202495B2 (en) 2002-01-11 2006-07-20 Sankyo Company, Limited Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
GB0217777D0 (en) * 2002-07-31 2002-09-11 Novartis Ag Organic compounds
IL165425A0 (en) * 2004-11-28 2006-01-15 Yeda Res & Dev Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
CN1767819B (zh) 2003-04-08 2010-07-28 诺瓦提斯公司 包含s1p受体激动剂和糖醇的固体药物组合物
EP1484057A1 (en) * 2003-06-06 2004-12-08 Aventis Pharma Deutschland GmbH Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
US7524887B2 (en) 2003-06-06 2009-04-28 Sanofi-Aventis Deutschland Gmbh 2-amino-1,3-propanediol compounds for the treatment of acute pain
PL1643983T3 (pl) * 2003-06-24 2010-10-29 Univ Connecticut Sposoby hamowania przepuszczalności naczyń krwionośnych i apoptozy
US7074659B2 (en) * 2003-11-13 2006-07-11 Volterra Semiconductor Corporation Method of fabricating a lateral double-diffused MOSFET (LDMOS) transistor
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물
ES2527055T3 (es) * 2004-07-30 2015-01-20 Novartis Ag Formulaciones de compuestos 2-amino-1,3-propanodiol
KR101346527B1 (ko) * 2005-12-15 2013-12-31 미쓰비시 타나베 파마 코퍼레이션 아민 화합물 및 그 의약 용도
JO3177B1 (ar) 2011-04-01 2018-03-08 Novartis Ag تركيبات تتالف من 2-أمينو-2- [ 2- ( 4- أكتيل فينيل ) إثيل ] بروبان - 3, 1- ديول
RU2496486C1 (ru) 2012-07-11 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция с улучшенной сыпучестью, лекарственное средство, способ получения и применение
AU2014224237B2 (en) * 2013-03-05 2017-07-20 Biocon Limited A process for the preparation of 2-amino-1,3-propane diol compounds and salts thereof
EP3143991B1 (en) 2015-09-18 2020-04-08 Sanovel Ilac Sanayi ve Ticaret A.S. Fingolimod capsule composition
CN115477590B (zh) * 2021-05-31 2023-12-12 上海云晟研新生物科技有限公司 芬戈莫德药用盐、制备方法、含其的药物组合物及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904679A (en) * 1972-05-23 1975-09-09 Upjohn Co 15-Methyl and 15-ethyl prostaglandin F{HD 2{331 {0 {B analogs
DE69233011T2 (de) * 1991-07-25 2003-11-06 Idec Pharmaceuticals Corp., San Diego Rekombinante antikörper zur humanen therapie
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5747034A (en) * 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
DE69321823T2 (de) 1992-10-21 1999-06-02 Taito Co., Ltd., Tokio/Tokyo 2-amino-1, 3- propandiolverbindung und immunosuppressium
RU2156127C2 (ru) * 1995-12-28 2000-09-20 Еситоми Фармасьютикал Индустриз, Лтд. Препарат местного применения для иммуносупрессии и лечения аутоиммунных или аллергических заболеваний
US6476004B1 (en) * 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
JP2002241272A (ja) * 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
PT990440E (pt) * 1997-02-27 2009-02-05 Novartis Ag Composição farmacêutica compreendendo 2-amino-2-[2-(4-octilfenil)etil]propano-1,3-diol, uma lecitina e um sacárido

Also Published As

Publication number Publication date
CN1293876C (zh) 2007-01-10
AU5483198A (en) 1998-06-10
HUP0000343A2 (hu) 2000-12-28
NO992259D0 (no) 1999-05-10
ES2227726T3 (es) 2005-04-01
CN1515253A (zh) 2004-07-28
CA2270952A1 (en) 1998-05-28
CN1237906A (zh) 1999-12-08
PL333463A1 (en) 1999-12-20
EP0941082B1 (en) 2004-09-15
SK284806B6 (sk) 2005-11-03
EP0941082A2 (en) 1999-09-15
WO1998022100A3 (en) 1998-06-25
ATE369846T1 (de) 2007-09-15
IL129824A (en) 2003-07-31
US20030069315A1 (en) 2003-04-10
RU2217136C2 (ru) 2003-11-27
US6486209B2 (en) 2002-11-26
JP2001503780A (ja) 2001-03-21
PT1312359E (pt) 2007-11-09
GB9624038D0 (en) 1997-01-08
JP2004256554A (ja) 2004-09-16
WO1998022100A2 (en) 1998-05-28
NZ335629A (en) 2001-09-28
EP1312359A2 (en) 2003-05-21
SI1312359T1 (sl) 2008-08-31
AU728420B2 (en) 2001-01-11
DE69738033D1 (de) 2007-09-27
ES2289041T3 (es) 2008-02-01
CA2270952C (en) 2007-09-18
NO992259L (no) 1999-05-10
PT941082E (pt) 2004-12-31
PL190348B1 (pl) 2005-11-30
US6274629B1 (en) 2001-08-14
BR9713105A (pt) 2000-04-11
CN1146411C (zh) 2004-04-21
IL129824A0 (en) 2000-02-29
DE69730727T2 (de) 2005-09-22
DK1312359T3 (da) 2007-10-08
ATE275947T1 (de) 2004-10-15
EP1312359A3 (en) 2004-01-02
US20010056124A1 (en) 2001-12-27
HUP0000343A3 (en) 2001-06-28
DE69730727D1 (de) 2004-10-21
CZ174999A3 (cs) 1999-08-11
JP4004070B2 (ja) 2007-11-07
SK65999A3 (en) 1999-12-10
HK1022639A1 (en) 2000-08-18
DE69738033T2 (de) 2008-04-30
EP1312359B1 (en) 2007-08-15

Similar Documents

Publication Publication Date Title
ID21568A (id) Penggunaan baru untuk turunan 1,3-propanadiol
PT870768E (pt) Derivados azaindole-etilamina como agentes de ligacao nicotinicos aos receptores de acetilcolina
DK0565721T3 (da) 1,4-Benzothiazepinderivat
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ATE93232T1 (de) Bis(methylendioxy)biphenyl-verbindungen.
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
ATE172463T1 (de) Pyrrolocarbazol
YU12992A (sh) 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu
ES2065994T3 (es) Beta-dicetonas substituidas.
ES2188481T3 (es) Derivados de polinalbufina.
DK0411394T3 (da) Imidazoquinolon-derivater
ES2066564T3 (es) Derivados de n-2-clorobencil-2-oxo y n-2-clorobencil-2,2-dioxo-1,2,3-oxatiazolidina, su preparacion y sintesis de derivados de tieno(3,2-c)piridina de estos.
DE69103985D1 (de) N-Alkylthiazolidinderivate.
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ES2062114T3 (es) Acidos 1,3-dioxalano benzoicos y derivados de los mismos.